Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): A unique target for the prevention and treatment of human melanoma

Antioxidants and Redox Signaling

Volumn 11, Issue 3, 2009, Pages 639-650

  Yang, Sun ^a   Meyskens Jr , Frank L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 3 [5 (2,3 DIMETHOXY 6 METHYL 1,4 BENZOQUINOYL)] 2 NONYL 2 PROPIONIC ACID; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CRT 0044876; DEFEROXAMINE; DISULFIRAM; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; E 3330; GLUTATHIONE; LUCANTHONE; METAL CHELATE; METAL DERIVATIVE; PNRI 299; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PYROLLIDINE DITHIOCARBAMATE; REDOX EFFECTOR FACTOR 1; RESVERATROL; UNCLASSIFIED DRUG; APEX1 PROTEIN, HUMAN;

CANCER GROWTH; CANCER PREVENTION; CANCER THERAPY; CELL SURVIVAL; CHELATION THERAPY; GENE MUTATION; HUMAN; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PUBLIC HEALTH; REVIEW; SIGNAL TRANSDUCTION; DRUG EFFECTS;

DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; HUMANS; MELANOMA;

EID: 58849160818     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2226     Document Type: Review

References (125)

1. Abola E, Kuhn P, Earnest T, and Stevens RC. Automation of X-ray crystallography. Nat Struct Biol 7(suppl): 973-977, 2000.
2. Agar N and Young AR. Melanogenesis: a photoprotective response to DNA damage? Mutation Res 571: 121-132, 2005.
3. Albrecht C, Knaapen AM, Becker A, Höhr D, Haberzettl P, van Schooten FJ, Borm PJ, and Schins RP. The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung. Respir Res 6: 129, 2005.
4. Amzel LM. Structure-based drug design. Curr Opin Biotechnol 9: 366-369, 1998.
5. Aubailly M, Santus R, and Salmon S. Ferrous ion release from ferritin by ultraviolet-A radiations. Photochem Photobiol 54: 769-773, 1991.
6. Bahbouth E, Siwek B, De Pauw-Gillet MC, Sabbioni E, and Bassleer R. Effects of trace metals on mouse B16 melanoma cells in culture. Biol Trace Elem Res 36(2): 191-201, 1993.
7. Barzilay G, Walker LJ, Robson CN, and Hickson ID. Site-directed mutagenesis of the human DNA repair enzyme HAP1: identification of residues important for AP endonuclease and RNase H activity. Nucleic Acids Res 23: 1544-1550, 1995.
8. Bennett DC. How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21: 27-38, 2008.
9. Berwick M. Pathways to the development of melanoma: a complex issue. J Invest Dermatol 126: 1932-1933, 2006.
10. Bickers DR and Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126: 2565-2575, 2006.
11. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, and Silber JR. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 11: 7405-7414, 2005.
12. Bode AM and Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 555: 33-51, 2004.
13. Bogacz A, Buszman E, and Wilczok T. Competition between metal ions for DOPA-melanin. Stud Biophys 132: 189-195, 1989.
14. Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signaling. Nat Rev Cancer 4: 23-35, 2004.
15. Briganti S and Picardo M. Antioxidant activity, lipid peroxidation and skin diseases: what's new. J Eur Acad Dermatol Venereol 17: 663-669, 2003.
16. Casadevall M, da Cruz Fresco P, and Kortenkamp A. Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chem Biol Interact 123: 117-132, 1999.
17. Cen D, Brayton D, Shahandeh B, Meyskens FL Jr, and Farmer PJ. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem 47: 6914-6920, 2004.
18. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, and Meyskens FL Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther 1: 197-204, 2002.
19. Cooper SJ and Bowden GT. Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets 7: 325-334, 2007.
20. Crowe DL, Brown TN, Kim R, Smith SM, and Lee MK. A c-fos/estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Mol Cell Biol Res Commun 3: 243-248, 2000.
21. Curiel-Lewandrowski C and Atkins MB. Immunotherapeutic approaches for the treatment of malignant melanoma. Curr Opin Invest Drugs 2: 1553-1563, 2001.
22. Curran RC and McCann BG. The ultrastructure of benign pigmented naevi and melanocarcinomas in man. J Pathol 119: 135-146, 1976.
23. Demierre MF and Sondak VK. Chemoprevention of melanoma: theoretical and practical considerations. Cancer Control 12: 219-222, 2005.
24. Dolcet X, Llobet D, Pallares J, and Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch 446: 475-482, 2005.
25. Eferl R and Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003.
26. Erzberger JP, Barsky D, Schärer OD, Colvin ME, and Wilson DM 3rd. Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucleic Acids Res 26: 2771-2778, 1998.
27. Evans AR, Limp-Foster M, and Kelley MR. Going APE over ref-1. Mutat Res 461: 83-108, 2000.
28. Farmer PJ, Gidanian S, Shahandeh B, Di Bilio AJ, Tohidian N, and Meyskens FL Jr. Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res 16: 273-279, 2003.
29. Faustin B and Reed JC. Sunburned skin activates inflammasomes. Trends Cell Biol 18: 4-8, 2008
30. Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, and Buzaid AC. Melanin content and downregulation of glutathione Stransferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma. Chem Biol Interact 111-112: 277-305, 1998.
31. Gidanian S, Mentelle M, Meyskens FL Jr, and Farmer PJ. Melanosomal damage in normal human melanocytes induced by UVB and metal uptake: a basis for the pro-oxidant state of melanoma. Photochem Photobiol 2008 (Epub ahead of print).
32. Gorbunov NV, Das DK, Goswami SK, Gurusamy N, and Atkins JL. Spatial coordination of cell-adhesion molecules and redox cycling of iron in the microvascular inflammatory response to pulmonary injury. Antioxid Redox Signal 9: 483-495, 2007.
33. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, and Gallick GE. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24: 3110-3120, 2005.
34. Hartwig A, Snyder RD, Schlepegrell R, and Beyersmann D. Modulation by Co(II) of UV-induced DNA repair, mutagenesis and sister-chromatid exchanges in mammalian cells. Mutat Res 248: 177-185, 1991.
35. Hazra TK, Das A, Das S, Choudhury S, Kow YW, and Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst) 6: 470-480, 2007.
36. He T, Weintraub NL, Goswami PC, Chatterjee P, Flaherty DM, Domann FE, and Oberley LW. Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 285(2): H804-H812, 2003.
37. Hearing VJ. Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci 37: 3-14, 2005.
38. Hengstler JG, Bolm-Audorff U, Faldum A, Janssen K, Reifenrath M, Götte W, Jung D, Mayer-Popken O, Fuchs J, Gebhard S, Bienfait HG, Schlink K, Dietrich C, Faust D, Epe B, and Oesch F. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis 24: 63-73, 2003.
39. Herrling T, Jung K, and Fuchs J. Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim Acta A Mol Biomol Spectrosc 63: 840-845, 2006.
40. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
41. Hol WG. Structural genomics for science and society. Nat Struct Biol 7(suppl): 964-966, 2000.
42. Hong L, Liu Y, and Simon JD. Binding of metal ions to melanin and their effects on the aerobic reactivity. Photochem Photobiol 80: 477-481, 2004.
43. Hong L and Simon JD. Current understanding of the binding sites, capacity, affinity, and biological significance of metals in melanin. J Phys Chem B 111: 7938-7947, 2007.
44. Hsieh MM, Hegde V, Kelley MR, and Deutsch WA. Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation. Nucleic Acids Res 29: 3116-3122, 2001.
45. Inoue J, Gohda J, Akiyama T, and Semba K. NF-kappaB activation in development and progression of cancer. Cancer Sci 98: 268-274, 2007.
46. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin 57: 43-66, 2007.
47. Juzeniene A, Juzenas P, Iani V, and Moan J. Topical applications of iron chelators in photosensitization. Photochem Photobiol Sci 6: 1268-1274, 2007.
48. Kasten U, Mullenders LH, and Hartwig A. Cobalt(II) inhibits the incision and the polymerization step of nucleotide excision repair in human fibroblasts. Mutat Res 383: 81-89, 1997.
49. Kelley MR, Parsons SH. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1. Antioxid Redox Signal 3: 671-683, 2001.
50. Khan N, Afaq F, and Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10: 475-510, 2008.
51. Klebe G. Recent developments in structure-based drug design. J Mol Med 78: 269-281. 2000.
52. Korohoda W, Michalik M, Pietzkowski Z, and Zaporowska-Siwiak E. Addition of iron and zinc complexes to Eagle's minimal essential medium is sufficient to induce and support the proliferation of B16 melanoma cells. Folia Histochem Cytobiol 31: 3-7, 1993.
53. Korytowski W, Pilas B, Sarna T, and Kalyanaraman B. Photoinduced generation of hydrogen peroxide and hydroxyl radicals in melanins. Photochem Photobiol 45: 185-190, 1987.
54. Kundu JK and Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 555: 65-80, 2004.
55. Kuphal S, Poser I, Jobin C, Hellerbrand C, and Bosserhoff AK. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23: 8509-8519, 2004.
56. Lando D, Pongratz I, Poellinger L, and Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J Biol Chem 275: 4618-4627, 2000.
57. Lau JP, Weatherdon KL, Skalski V, and Hedley DW. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 91: 1166-1173, 2004.
58. Leonard S, Gannett PM, Rojanasakul Y, Schwegler-Berry D, Castranova V, Vallyathan V, and Shi X. Cobalt-mediated generation of reactive oxygen species and its possible mechanism. J Inorg Biochem 70: 239-244, 1998.
59. Levin JD, Shapiro R, and Demple B. Metalloenzymes in DNA repair. Escherichia coli endonuclease IV and Saccharomyces cerevisiae Apn1. J Biol Chem 266: 22893-22898, 1991.
60. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, and Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11: 447-460, 2007.
61. Luo M, Delaplane S, Jiang A, Reed A, He Y, Fishel M, Nyland RL, Borch RF, Qiao X, Georgiadis MM, Kelley MR. Role of the multifunctional DNA repair and redox signaling protein ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of ape1. Antioxid Redox Signal, 2008 [Epub ahead of print].
62. Luo M and Kelley MR. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res 24: 2127-2134, 2004.
63. Madhusudan S, Smart F, Shrimpton P, Parsons JL, Gardiner L, Houlbrook S, Talbot DC, Hammonds T, Freemont PA, Sternberg MJ, Dianov GL, and Hickson ID. Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Res 33: 4711-4724. 2005.
64. Magnani M, Crinelli R, Bianchi M, Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets 1: 387-399, 2000.
65. Maxwell P and Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 3: 29-35, 2004.
66. McNeill DR, Narayana A, Wong HK, and Wilson DM 3rd. Inhibition of Ape1 nuclease activity by lead, iron, and cadmium. Environ Health Perspect 112: 799-804, 2004.
67. McNulty SE, del Rosario R, Cen D, Meyskens FL Jr, and Yang S. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Res 17: 173-180, 2004.
68. McNulty SE, Tohidian NB, and Meyskens FL Jr. RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. Pigment Cell Res 14: 456-465, 2001.
69. Melnikova I and Golden J. Apoptosis-targeting therapies. Nat Rev Drug Discov 3: 905-906, 2004.
70. Melnikova VO and Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 571: 91-106, 2005.
71. Mendez F, Goldman JD, and Bases RE. Abasic sites in DNA of HeLa cells induced by lucanthone. Cancer Invest 20: 983-991, 2002.
72. Meo SA and Al-Khlaiwi T. Health hazards of welding fumes. Saudi Med J 24: 1176-1182, 2003.
73. Meyskens FL Jr, Buckmeier JA, McNulty SE, and Tohidian NB. Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress. Clin Cancer Res 5: 1197-1202, 1999.
74. Meyskens FL Jr, Chau HV, Tohidian N, and Buckmeier J. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res 10: 184-189, 1997.
75. Meyskens FL Jr, Farmer PJ, Anton-Culver H. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 10: 2581-2583, 2004.
76. Meyskens FL Jr, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, and Gonzalez RI. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 31: 799-808, 2001.
77. Minisini AM, Di Loreto C, Mansutti M, Artico D, Pizzolitto S, Piga A, and Puglisi F. Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer. Cancer Lett 224: 133-139, 2005.
78. Mitani H, Koshiishi I, Sumita T, and Imanari T. Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol 411: 169-174, 2001.
79. Nguyen C, Teo JL, Matsuda A, Eguchi M, Chi EY, Henderson WR Jr, and Kahn M. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A 100: 1169-1173, 2003.
80. Noble ME, Endicott JA, and Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science 303: 1800-1805, 2004.
81. Nyrén O, McLaughlin JK, Gridley G, Ekbom A, Johnell O, Fraumeni JF Jr, and Adami HO. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 87: 28-33, 1995.
82. O'Hara AM, Bhattacharyya A, Mifflin RC, Smith MF, Ryan KA, Scott KG, Naganuma M, Casola A, Izumi T, Mitra S, Ernst PB, and Crowe SE. Interleukin-8 induction by Helicobacter pylori in gastric epithelial cells is dependent on apurinic/apyrimidinic endonuclease-1/redox factor-1. J Immunol 177: 7990-7999, 2006.
83. Onega T, Baron J, and MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1532-1537, 2006.
84. Palumbo A, d'Ischia M, Misuraca G, Prota G, and Schultz TM. Structural modifications in biosynthetic melanins induced by metal ions. Biochim Biophys Acta 964: 193-199, 1988.
85. Picardo M, Grammatico P, Roccella F, Roccella M, Grandinetti M, Del Porto G, and Passi S. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 107: 322-326, 1996.
86. Pierson HF. Enhancement of tumorigenicity of B16 melanoma in heterogenetic mice by administration of copper chelates. Cancer Treat Rep 69: 1283-1291, 1985.
87. Pilas B, Sarna T, Kalyanaraman B, and Swartz HM. The effect of melanin on iron associated decomposition of hydrogen peroxide. Free Radic Biol Med 4: 285-293, 1988.
88. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gulisano M, Kelley MR, Quadrifoglio F, and Tell G. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33: 4379-4394, 2005.
89. Piret JP, Mottet D, Raes M, and Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 973: 443-447, 2002.
90. Poser I and Bosserhoff AK. Transcription factors involved in development and progression of malignant melanoma. Histol Histopathol 19: 173-188, 2004.
91. Qu J, Liu GH, Huang B, and Chen C. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res 35: 2522-2532, 2007.
92. Rahmani M, Péron P, Weitzman J, Bakiri L, Lardeux B, and Bernuau D. Functional cooperation between JunD and NFkappaB in rat hepatocytes. Oncogene 20: 5132-5142, 2001.
93. Ralph SJ. An update on malignant melanoma vaccine research: insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines. Am J Clin Dermatol 8: 123-141, 2007.
94. Reelfs O, Tyrrell RM, and Pourzand C. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts. J Invest Dermatol 122: 1440-1447, 2004.
95. Rezvani HR, Dedieu S, North S, Belloc F, Rossignol R, Letellier T, de Verneuil H, Taïeb A, and Mazurier F. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem 282: 16413-16422, 2007.
96. Rhodes AR, Seki Y, Fitzpatrick TB, and Stern RS. Melanosomal alterations in dysplastic melanocytic nevi: a quantitative, ultrastructural investigation. Cancer 61: 358-369, 1988.
97. Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A, and Cippitelli M. bcl-2 Overexpression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer 86: 188-196, 2000.
98. Rigel DS and Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 50: 215-236, 2000.
99. Rivers JK and Gallagher RP. Public education projects in skin cancer: experience of the Canadian Dermatology Association. Cancer 75(2 suppl): 661-666, 1995.
100. Rivers JK. Is there more than one road to melanoma? Lancet 363: 728-730, 2004.
101. Roth M and Black JL. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 7: 589-595, 2006.
102. Sak SC, Harnden P, Johnston CF, Paul AB, and Kiltie AE. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res 11: 6205-6211, 2005.
103. Sander CS, Chang H, Hamm F, Elsner P, and Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 43: 326-335, 2004.
104. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, and Brenner DA. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37: 824-832, 2003.
105. Silva M, Heisel C, and Schmalzried TP. Metal-on-metal total hip replacement. Clin Orthop Relat Res 430: 53-61, 2005.
106. Snyder RD, Davis GF, and Lachmann PJ. Inhibition by metals of x-ray and ultraviolet-induced DNA repair in human cells. Biol Trace Elem Res 21: 389-398, 1989.
107. Svobodova A, Walterova D, and Vostalova J. Ultraviolet light induced alteration to the skin. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150: 25-38, 2006.
108. Tanner B, Grimme S, Schiffer I, Heimerdinger C, Schmidt M, Dutkowski P, Neubert S, Oesch F, Franzen A, Kölbl H, Fritz G, Kaina B, and Hengstler JG. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecol Oncol 92: 568-577, 2004.
109. Tell G, Damante G, Caldwell D, and Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 7: 367-384, 2005.
110. Thomas NE, Berwick M, and Cordeiro-Stone M. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation? J Invest Dermatol 126: 1693-1696, 2006.
111. Toualbi-Abed K, Daniel F, Güller MC, Legrand A, Mauriz JL, Mauviel A, and Bernuau D. Jun D cooperates with p65 to activate the proximal kappaB site of the cyclin D1 promoter: role of PI3K/PDK-1. Carcinogenesis 29: 536-543, 2008.
112. Tsou TC, Chen CL, Liu TY, and Yang JL. Induction of 8- hydroxydeoxyguanosine in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers. Carcinogenesis 17: 103-108, 1996.
113. Visuri TI, Pukkala E, Pulkkinen P, and Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech Eng [H] 220: 399-407, 2006.
114. Wagner M, Klein CL, Kleinert H, Euchenhofer C, Förstermann U, and Kirkpatrick CJ. Heavy metal ion induction of adhesion molecules and cytokines in human endothelial cells: the role of NF-kappaB, I kappaB-alpha and AP-1. Pathobiology 65: 241-252, 1997.
115. Wang D, Luo M, and Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3: 679-686, 2004.
116. Wang D, Zhong ZY, Li MX, Xiang DB, and Li ZP. Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo. Cancer Sci 98: 1993-2001, 2007.
117. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, and Gius D. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 60: 6688-6695, 2000.
118. rd and Barsky D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 485: 283-307, 2001.
119. Wondrak GT. Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr Opin Invest Drugs 8: 390-400, 2007.
120. Yang S, Irani K, Heffron SE, Jurnak F, and Meyskens FL Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 4: 1923-1935, 2005.
121. Yang S, McNulty S, and Meyskens FL Jr. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res 17: 74-83, 2004.
122. Yang S, Misner BJ, Chiu RJ, Meyskens FL Jr. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis 28: 2382-2390, 2007.
123. Yiakouvaki A, Savovië J, Al-Qenaei A, Dowden J, and Pourzand C. Caged-iron chelators a novel approach towards protecting skin cells against UVA-induced necrotic cell death. J Invest Dermatol 126: 2287-2295, 2006.
124. Zareba M, Bober A, Korytowski W, Zecca L, and Sarna T. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. Biochim Biophys Acta 1271: 343-348, 1995.
125. Ziel KA, Campbell CC, Wilson GL, and Gillespie MN. Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J 18: 986-988, 2004.